조산 및 조기 양막 파열(PROM) 검사 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Preterm Birth And PROM Testing Market size is expected to reach USD 5.06 Billion in 2034 from USD 2.36 Billion (2025) growing at a CAGR of 8.86% during 2026-2034.

The Global Preterm Birth and PROM Testing Market is growing as maternal healthcare prioritizes early detection of premature rupture of membranes (PROM) and preterm labor risk. These conditions contribute significantly to neonatal morbidity and healthcare costs. Diagnostic tests that identify biomarkers, infection markers, or membrane changes help clinicians intervene earlier to improve maternal and fetal outcomes.

Rising global birth rates and expanding prenatal care infrastructure in emerging markets increase demand for reliable testing kits. Healthcare providers are adopting advanced screening protocols as part of routine prenatal evaluations. Improved accessibility and awareness are encouraging women to seek timely prenatal assessments.

Future prospects look positive as biotechnology advances refine test accuracy and speed. Development of point-of-care and noninvasive testing options will broaden adoption. Integration with telehealth services could improve remote maternal monitoring. Continued investment into research and clinical validation will sustain market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Test Type

• Pelvic Exam
• Ultrasound
• Biochemical Markers
• Uterine Monitoring
• Nitazine Test
• Ferning Test
• Pooling
• Pamg-1 Immunoassay
• IGFBP Test
• Fetal Fibronectin (fFn)
• Others

By End User

• Hospitals
• Diagnostics Laboratories
• Outpatient Clinics
• Research Centers
• Others

COMPANIES PROFILED

• Qiagen NV, Hologic Inc, Cooper Surgical Inc, Abbott, Medixbiochemica, Sera prognostics, Clinical Innovations LLC, Biosynex, NX Prenatal Inc, IQ Products
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL PRETERM BIRTH AND PROM TESTING MARKET: BY TEST TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Test Type
• 4.2. Pelvic Exam Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Ultrasound Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Biochemical Markers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Uterine Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Nitazine Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Ferning Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Pooling Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Pamg-1 Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.10. IGFBP Test Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.11. Fetal Fibronectin (fFn) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.12. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL PRETERM BIRTH AND PROM TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Outpatient Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Research Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL PRETERM BIRTH AND PROM TESTING MARKET: BY REGION 2022-2034(USD MN)

• 6.1. Regional Outlook
• 6.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.2.1 By Test Type
  • 6.2.2 By End User
  • 6.2.3 United States
  • 6.2.4 Canada
  • 6.2.5 Mexico
• 6.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.3.1 By Test Type
  • 6.3.2 By End User
  • 6.3.3 United Kingdom
  • 6.3.4 France
  • 6.3.5 Germany
  • 6.3.6 Italy
  • 6.3.7 Russia
  • 6.3.8 Rest Of Europe
• 6.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.4.1 By Test Type
  • 6.4.2 By End User
  • 6.4.3 India
  • 6.4.4 Japan
  • 6.4.5 South Korea
  • 6.4.6 Australia
  • 6.4.7 South East Asia
  • 6.4.8 Rest Of Asia Pacific
• 6.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.5.1 By Test Type
  • 6.5.2 By End User
  • 6.5.3 Brazil
  • 6.5.4 Argentina
  • 6.5.5 Peru
  • 6.5.6 Chile
  • 6.5.7 South East Asia
  • 6.5.8 Rest of Latin America
• 6.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 6.6.1 By Test Type
  • 6.6.2 By End User
  • 6.6.3 Saudi Arabia
  • 6.6.4 UAE
  • 6.6.5 Israel
  • 6.6.6 South Africa
  • 6.6.7 Rest of the Middle East And Africa

Chapter 7. COMPETITIVE LANDSCAPE

• 7.1. Recent Developments
• 7.2. Company Categorization
• 7.3. Supply Chain & Channel Partners (based on availability)
• 7.4. Market Share & Positioning Analysis (based on availability)
• 7.5. Vendor Landscape (based on availability)
• 7.6. Strategy Mapping

Chapter 8. COMPANY PROFILES OF GLOBAL PRETERM BIRTH AND PROM TESTING INDUSTRY

• 8.1. Top Companies Market Share Analysis
• 8.2. Company Profiles
  • 8.2.1 Qiagen N.V
  • 8.2.2 Hologic Inc
  • 8.2.3 Cooper Surgical Inc
  • 8.2.4 Abbott
  • 8.2.5 Medixbiochemica
  • 8.2.6 Sera Prognostics
  • 8.2.7 Clinical Innovations LLC
  • 8.2.8 Biosynex
  • 8.2.9 NX Prenatal Inc
  • 8.2.10 IQ Products